Noninvasive targeted modulation of pain circuits with focused ultrasonic waves.
Authors: Riis TS, Feldman DA, Losser AJ, Okifuji A, Kubanek J
Direct interventions into deep brain circuits constitute promising treatment modalities for chronic pain. Cingulotomy and deep brain stimulation targeting the anterior cingulate cortex have shown notable improvements in the unpleasantness of pain, but these interventions require brain surgeries. In this study, we have developed an approach that can modulate this deep brain affective hub entirely noninvasively, using low-intensity transcranial-focused ultrasound. Twenty patients with chronic pain received two 40-minute active or sham stimulation protocols and were monitored for one week in a randomized crossover trial. Sixty percent of subjects experienced a clinically meaningful reduction of pain on day 1 and on day 7 following the active stimulation, while sham stimulation provided such benefits only to 15% and 20% of subjects, respectively. On average, active stimulation reduced pain by 60.0% immediately following the intervention and by 43.0% and 33.0% on days 1 and 7 following the intervention. The corresponding sham levels were 14.4%, 12.3%, and 6.6%. The stimulation was well tolerated, and no adverse events were detected. Side effects were generally mild and resolved within 24 hours. Together, the direct, ultrasonic stimulation of the anterior cingulate cortex offers rapid, clinically meaningful, and durable improvements in pain severity.
Introduction
Purpose
Transcranial ultrasound stimulation
Study Objective
To develop and test a noninvasive low-intensity transcranial-focused ultrasound approach to modulate the anterior cingulate cortex and reduce chronic pain.
Disease model
Chronic pain
Targeted brain region(s)
Anterior Cingulate Cortex
Outcomes and Safety
Summary of Outcomes
Two 40-minute sessions of LIFU targeting the anterior cingulate cortex produced substantial pain reductions (mean 60% immediately, 43% at day 1, 33% at day 7) with 60% of subjects achieving clinically meaningful improvement at days 1 and 7
Duration of biological effect
7 days
Safety-related matter
No adverse events were detected; side effects were mild and resolved within 24 hours
Brain Region
Ultrasound Parameters
Ultrasound instrument
not reported
FUS Frequency
not reported
FUS Intensity
not reported
FUS Pressure
not reported
FUS Mode
not reported
Pulse duration
not reported
Duration of a single FUS session
40 minutes
Treatment frequency
Multiple sessions
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search